Latest Yiheng Capital Management, L.P. Stock Portfolio
Yiheng Capital Management, L.P. Performance:
2025 Q4: -3.21%YTD: 19.57%2024: 10.62%
Performance for 2025 Q4 is -3.21%, and YTD is 19.57%, and 2024 is 10.62%.
About Yiheng Capital Management, L.P. and 13F Hedge Fund Stock Holdings
On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, Yiheng Capital Management, L.P. reported an equity portfolio of $494.3 Millions as of 31 Dec, 2025.
The top stock holdings of Yiheng Capital Management, L.P. are NOAH, BILI, JD. The fund has invested 13.6% of it's portfolio in NOAH HLDGS LTD and 5.7% of portfolio in BILIBILI INC.
The fund managers got completely rid off AKERO THERAPEUTICS INC (AKRO), DENALI THERAPEUTICS INC (DNLI) and ULTRAGENYX PHARMACEUTICAL IN (RARE) stocks. They significantly reduced their stock positions in INVENTIVA SA (IVA), BEAM THERAPEUTICS INC (BEAM) and VIRIDIAN THERAPEUTICS INC (VRDN). Yiheng Capital Management, L.P. opened new stock positions in FULL TRUCK ALLIANCE CO LTD (YMM) and PASSAGE BIO INC (PASG). The fund showed a lot of confidence in some stocks as they added substantially to YATSEN HLDG LTD (YSG) and PONY AI INC.
The top stock holdings of Yiheng Capital Management, L.P. are NOAH, BILI, JD. The fund has invested 13.6% of it's portfolio in NOAH HLDGS LTD and 5.7% of portfolio in BILIBILI INC.
The fund managers got completely rid off AKERO THERAPEUTICS INC (AKRO), DENALI THERAPEUTICS INC (DNLI) and ULTRAGENYX PHARMACEUTICAL IN (RARE) stocks. They significantly reduced their stock positions in INVENTIVA SA (IVA), BEAM THERAPEUTICS INC (BEAM) and VIRIDIAN THERAPEUTICS INC (VRDN). Yiheng Capital Management, L.P. opened new stock positions in FULL TRUCK ALLIANCE CO LTD (YMM) and PASSAGE BIO INC (PASG). The fund showed a lot of confidence in some stocks as they added substantially to YATSEN HLDG LTD (YSG) and PONY AI INC.
Yiheng Capital Management, L.P. Annual Return Estimates Vs S&P 500
Our best estimate is that Yiheng Capital Management, L.P. made a return of -3.21% in the last quarter. In trailing 12 months, it's portfolio return was 19.57%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| full truck alliance co ltd | 4,411,560 |
| passage bio inc | 404,752 |
New stocks bought by Yiheng Capital Management, L.P.
Additions
| Ticker | % Inc. |
|---|---|
| yatsen hldg ltd | 282 |
| pony ai inc | 226 |
Additions to existing portfolio by Yiheng Capital Management, L.P.
Reductions
| Ticker | % Reduced |
|---|---|
| inventiva sa | -90.32 |
| beam therapeutics inc | -69.41 |
| viridian therapeutics inc | -58.27 |
| kymera therapeutics inc | -40.1 |
| acm resh inc | -37.74 |
| new oriental ed & technology | -34.73 |
| bilibili inc | -19.01 |
| h world group ltd | -12.84 |
Yiheng Capital Management, L.P. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| denali therapeutics inc | -6,824,120 |
| cellebrite di ltd | -4,281,000 |
| ultragenyx pharmaceutical in | -6,790,800 |
| akero therapeutics inc | -9,072,290 |
Yiheng Capital Management, L.P. got rid off the above stocks
Sector Distribution
Yiheng Capital Management, L.P. has about 85.6% of it's holdings in Others sector.
- Others
- Healthcare
- Technology
| Sector | % |
|---|---|
| Others | 85.6 |
| Healthcare | 11.4 |
| Technology | 3 |
Market Cap. Distribution
Yiheng Capital Management, L.P. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
| Category | % |
|---|---|
| UNALLOCATED | 85.6 |
| MID-CAP | 13.9 |
Stocks belong to which Index?
About 8.8% of the stocks held by Yiheng Capital Management, L.P. either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 91.2 |
| RUSSELL 2000 | 8.8 |
Yiheng Capital Management, L.P. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Yiheng Capital Management, L.P.
Yiheng Capital Management, L.P. has 21 stocks in it's portfolio. About 41.4% of the portfolio is in top 10 stocks. NOAH proved to be the most loss making stock for the portfolio. DBVT was the most profitable stock for Yiheng Capital Management, L.P. last quarter.
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACMR | acm resh inc | 1.39 | 174,447 | 6,881,930 | reduced | -37.74 | ||
| AKRO | akero therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| API | agora inc | 0.44 | 533,547 | 2,171,540 | unchanged | 0.00 | ||
| BEAM | beam therapeutics inc | 0.12 | 21,126 | 585,613 | reduced | -69.41 | ||
| BILI | bilibili inc | 5.72 | 1,148,900 | 28,251,400 | reduced | -19.01 | ||
| CLBT | cellebrite di ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DBVT | dbv technologies s a | 2.48 | 639,769 | 12,264,400 | reduced | -2.52 | ||
| DNLI | denali therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| EDU | new oriental ed & technology | 3.79 | 340,629 | 18,744,800 | reduced | -34.73 | ||
| GBIO | generation bio co | 0.12 | 105,524 | 599,376 | unchanged | 0.00 | ||
| HTHT | h world group ltd | 3.79 | 398,371 | 18,743,400 | reduced | -12.84 | ||
| IVA | inventiva sa | 0.24 | 255,915 | 1,190,000 | reduced | -90.32 | ||
| JD | jd.com inc | 3.99 | 687,413 | 19,728,800 | reduced | -12.7 | ||
| KYMR | kymera therapeutics inc | 1.16 | 73,440 | 5,714,370 | reduced | -40.1 | ||
| NOAH | noah hldgs ltd | 13.64 | 6,717,350 | 67,442,200 | unchanged | 0.00 | ||
| PASG | passage bio inc | 0.08 | 34,301 | 404,752 | new | |||
| RARE | ultragenyx pharmaceutical in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RERE | atrenew inc | 3.39 | 3,163,120 | 16,764,500 | unchanged | 0.00 | ||
| TAL | tal education group | 0.68 | 309,240 | 3,373,810 | unchanged | 0.00 | ||
| TOUR | tuniu corp | 0.04 | 314,437 | 194,951 | unchanged | 0.00 | ||